Balaji Venkataraman - Net Worth and Insider Trading

Balaji Venkataraman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Balaji Venkataraman owns 6 companies in total, including Amplitude Healthcare Acquisition Corp (AMHCU) , Progenics Pharmaceuticals Inc (PGNX) , and Horizon Therapeutics PLC (HZNP) among others .

Click here to see the complete history of Balaji Venkataraman’s form 4 insider trades.

Insider Ownership Summary of Balaji Venkataraman

Ticker	Comapny	Transaction Date	Type of Owner
AMHCU	Amplitude Healthcare Acquisition Corp	2020-01-03	director & 10 percent owner & Chief Executive Officer
PGNX	Progenics Pharmaceuticals Inc	2019-09-09	10 percent owner & other: See Explanation of Responses
HZNP	Horizon Therapeutics PLC	2014-09-22	10 percent owner
JSPR	Jasper Therapeutics Inc	2023-01-25	10 percent owner
HRTX	Heron Therapeutics Inc	2023-01-30	other: See Footnote 2
ALIM	Alimera Sciences Inc	2023-05-17	10 percent owner

Balaji Venkataraman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Balaji Venkataraman Ownership Network

Ownership Network List of Balaji Venkataraman

No Data

Ownership Network Relation of Balaji Venkataraman

Balaji Venkataraman Owned Company Details

What does Amplitude Healthcare Acquisition Corp do?

Who are the key executives at Amplitude Healthcare Acquisition Corp?

Balaji Venkataraman is the director & 10 percent owner & Chief Executive Officer of Amplitude Healthcare Acquisition Corp. Other key executives at Amplitude Healthcare Acquisition Corp include 10 percent owner Glazer Capital, Llc , 10 percent owner Paul J Glazer , and President Vishal Kapoor .

Amplitude Healthcare Acquisition Corp (AMHCU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Amplitude Healthcare Acquisition Corp (AMHCU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Amplitude Healthcare Acquisition Corp (AMHCU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Amplitude Healthcare Acquisition Corp (AMHCU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amplitude Healthcare Acquisition Corp Insider Transactions

No Available Data

What does Progenics Pharmaceuticals Inc do?

Who are the key executives at Progenics Pharmaceuticals Inc?

Balaji Venkataraman is the 10 percent owner & other: See Explanation of Responses of Progenics Pharmaceuticals Inc. Other key executives at Progenics Pharmaceuticals Inc include Chief Medical Officer Asha Das , 10 percent owner & other: See Explanation of Responses Virinder Nohria , and 10 percent owner Broadfin Healthcare Master Fund Ltd .

Progenics Pharmaceuticals Inc (PGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Progenics Pharmaceuticals Inc (PGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Progenics Pharmaceuticals Inc (PGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Progenics Pharmaceuticals Inc (PGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Progenics Pharmaceuticals Inc Insider Transactions

No Available Data

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Balaji Venkataraman is the 10 percent owner of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

Over the past 18 months, Balaji Venkataraman made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Horizon Therapeutics PLC Insider Transactions

No Available Data

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Balaji Venkataraman is the 10 percent owner of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Balaji Venkataraman made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net purchase of 50,000 shares made by Thomas G Wiggans , a net purchase of 3,323,333 shares made by Carlyle Group Inc. , and a net sale of 16,465 shares made by William Lis .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 540,000 shares, with a net purchase of 539,100 shares. During the past 18 months, 12,554 shares of Jasper Therapeutics Inc (JSPR) were sold and 1,125,000 shares were bought by its insiders, resulting in a net purchase of 1,112,446 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jasper Therapeutics Inc Insider Transactions

No Available Data

What does Heron Therapeutics Inc do?

Who are the key executives at Heron Therapeutics Inc?

Balaji Venkataraman is the other: See Footnote 2 of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .

Heron Therapeutics Inc (HRTX) Insider Trades Summary

Over the past 18 months, Balaji Venkataraman made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Heron Therapeutics Inc Insider Transactions

No Available Data

What does Alimera Sciences Inc do?

Who are the key executives at Alimera Sciences Inc?

Balaji Venkataraman is the 10 percent owner of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .

Alimera Sciences Inc (ALIM) Insider Trades Summary

Over the past 18 months, Balaji Venkataraman made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alimera Sciences Inc Insider Transactions

No Available Data

Balaji Venkataraman Mailing Address

Above is the net worth, insider trading, and ownership report for Balaji Venkataraman. You might contact Balaji Venkataraman via mailing address: First Horizon Pharmaceutical Corp, 660 Hembree Pkwy Ste 106, Roswell Ga 30076.

Discussions on Balaji Venkataraman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.